Patent applications published 1 September 2010
Selected patent applications from the weekly European Patents Bulletin
- Cryopreservation of cells using cross-linked bioactive hydrogel matrix particles
Pioneer Surgical Orthobiologics 2222159*
- Haloallylamine inhibitors of SSAO/VAP-1 and uses therefor
Pharmaxis 2222160*
- Quinoxyalinyl derivatives
Enanta Pharmaceuticals 2222161*
- Small molecule myristate inhibitors of BCR-ABL and methods of use
Dana Farber Cancer Institute 2222162*
- Nove compounds as cannabinoid receptor ligands and uses thereof
Abbott Laboratories 2222165*
- Heterocyclic kinase inhibitors
Concert Pharmaceuticals 2222166*
- Methods and compsns for inhibiting integrins using tellurium-containing compounds
Biomas 2222167*
- Respiratory disease treatment
Pulmagen Therapeutics (Inflammation) 2222272*
- Liquid compsns comprising valsartan
Novartis 2222273*
- Methods and compsns for enhancing the viability of microneedle pores
AllTranz 2222274*
- Pharmaceutical compsns containing bradykinin antagonists and hyaluronic acid, and uses thereof
Istituto Luso Farmaco d’Italia 2222275*
- Stable elsamitrucin salt formulations
Spectrum Pharmaceuticals 2222276*
- Pegylated liposomal formulations for photodynamic treatment of inflammatory diseases
CeramOptec 2222277*
- Improved taxane delivery system
Celator Pharmaceuticals 2222278*
- Acoustically sensitive drug delivery particles comprising non-lamellar forming lipids
Epitarget 2222279*
- Slow release compsns
The University of Strathclyde 2222280*
- Process for preparing microparticles having a low residual solvent volume
Surmodics Pharmaceuticals 2222281*
- Dosage forms comprising celecoxib providing both rapid and sustained pain relief
Pfizer Products 2222282*
- Yeast cell wall protein (YCWP) encapsulated multilayered nanoparticles for nucleic drug delivery (SIRNA)
University of Massachusetts 2222283*
- Prolonged release of local anaesthetics using microparticles and surgery applications
Capsulated Systems 2222284*
- Pharmaceutical compsns
Vifor (International) 2222285*
- Corticosteroids to treat epothilone or epothilone derivative induced diarrhoea
Novartis 2222286*
- Multitarget compounds active at a PPAR and cannabinoid receptor
Giuliani International 2222287*
- Use of an ozone/oxygen mixture as primary anticancer therapy through intraperitoneal insufflation
Philipps-Universität Marburg 2222288*
- Treatment of oral pharyngeal dysphagia
Nestec 2222289*
- Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders
Newron Pharmaceuticals 2222290*
- Compounds for the selective treatment of the intestinal immuno-inflammatory component of the coeliac disease
Giuliani International 2222291*
- Novel use of omega-3-fatty acid(s)
KD Pharma Bexbach 2222292*
- Medicinal use of 3-(2,2,2-trimethyl-hydrazinium) propionate hydrogen fumarate and dihydrogen phosphate
Grindeks, a joint stock company 2222293*
- Compsns comprising stilbene polyphenol derivatives and use thereof for combating the ageing of living organisms and diseases affecting the same
Caudalie 2222294*
- Pharmaceutical compsns for treatment and prevention of kidney diseases
Mezance 2222295*
- AMPA receptor antagonists and zonisamide for epilepsy
Eisai R&D Management 2222296*
- Compsns and methods for inhibiting the activation of DSRNA-dependent protein kinase and tumour growth inhibition
Nestec 2222297*
- Use of CFMS inhibitor for treating or preventing bone cancer and the bone loss and bone pain associated with bone cancer
Janssen Pharmaceutica 2222298*
- Use of levocabastine for modulating generation of pro-inflammatory cytokines
Bausch & Lomb 2222299*
- Method and compsns for treating a serotonin receptor-mediated condition
Vanda Pharmaceuticals 2222300*
- Method and compsn for treating an alpha adrenoreceptor-mediated condition
Vanda Pharmaceuticals 2222301*
- A method of treating over-eating disorders
NeuroSearch 2222302*
- A method for treating addiction
NeuroSearch 2222303*
- Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
Vertex Pharmaceuticals 2222304*
- Methods for reducing blood pressure
Fibrogen 2222305*
- 2-amino purine derivatives and their use as anti-herpetic agents
Exley, Ray 2222306*
- Use of amorolfine for treating a nail disease by iontophoresis
Galderma 2222307*
- N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors
NeuroSearch 2222308*
- Antibiotic macrocycle compounds and methods of manufacture and use thereof
Optimer Pharmaceuticals 2222309*
- Preparation for treating intestinal infection comprising oligosaccharides and insoluble cellular material
Fayrefield Foods 2222310*
- Liquid nucleotides/nucleosides-containing product
NV Nutricia 2222311*
- Liquid nucleotides/nucleosides-containing product